Lloyd Mencinger

Lloyd Mencinger is an accomplished executive with extensive experience in the medical device and healthcare sectors. Currently serving as President & CEO of Aqua Medical Inc. since January 2017, Mencinger leads initiatives utilizing innovative vapor-based ablation technology aimed at treating type 2 diabetes and preventing esophageal and pancreatic cancers. Previous roles include Principal Advisor at Larta Institute, Vice President International at DFINE, and Vice President Sales & Marketing at EndoStim. Mencinger has also held notable positions within Tenet Healthcare as Senior Vice President of Business Development & Marketing, and within Boston Scientific across various executive capacities, including Vice President of Global Business Development & Strategy. Educational qualifications include an MBA from USC Marshall School of Business and a B.S. in Chemical Engineering from California State University, Long Beach, both with Cum Laude honors, alongside additional studies at Harvard Business School and The University of Chicago Booth School of Business.